Bipolar II Disorder: Frequent, Valid, and Reliable.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Breaking Through Barriers: The Transformative Potential of Nanomedicine in Overcoming Drug Delivery Challenges for Psychiatric Disorders.CNS & neurological disorders drug targets · 2026
   Review
2. Bipolar II disorder: a state-of-the-art review.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
   Article
3. White and gray matter alterations in bipolar I and bipolar II disorder subtypes compared with healthy controls - exploring associations with disease course and polygenic risk.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
   Article
4. Differential characteristics of bipolar I and II disorders: a retrospective, cross-sectional evaluation of clinical features, illness course, and response to treatment.International journal of bipolar disorders · 2023
   Article
5. Barriers to timely identification of bipolar disorder in youth: a multidimensional perspective.Frontiers in child and adolescent psychiatry · 2023
   Article
6. Bipolar disorder in the International Classification of Diseases-Eleventh version: A review of the changes, their basis, and usefulness.World journal of psychiatry · 2022
   Review
7. Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study.JAMA psychiatry · 2022
   Article
8. Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force.Bipolar disorders · 2021
   Review
9. Identification of potential plasma protein biomarkers for bipolar II disorder: a preliminary/exploratory study.Scientific reports · 2021
   Article
10. The existential crisis of bipolar II disorder.International journal of bipolar disorders · 2020
    Review

Corrections and comments

• Comment on
  Bipolar II Disorder Is a Myth.2019

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as